Sarepta Therapeutics
SRPT
$81.28
Share price
1.09%
Change (1 day)
-33.82%
Change (1 year)
Categories
Sarepta Therapeutics is an American medical research company dedicated to the discovery and development of precisely effective gene therapeutics for the treatment of rare neuromuscular diseases.
Earnings for Sarepta Therapeutics (SRPT)
Earnings in 2023 (TTM): -$0.67 B
According to Sarepta Therapeutics 's latest financial reports the company's current earnings (TTM) are -$0.67 B. In 2022 the company made an earning of -$0.69 B a decrease over its 2021 earnings that were of -$0.42 B.The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.
Earnings history for Sarepta Therapeutics from 2001 to 2023
Annual earnings
| Year | Earnings | Change |
|---|---|---|
| 2023 (TTM) | -$0.67 B | -4.09% |
| 2022 | -$0.69 B | 64.69% |
| 2021 | -$0.42 B | -24.25% |
| 2020 | -$0.56 B | -22.53% |
| 2019 | -$0.72 B | 96.87% |
| 2018 | -$0.37 B | 645.68% |
| 2017 | -$48.63 M | -81.81% |
| 2016 | -$0.27 B | 21.47% |
| 2015 | -$0.23 B | 62.04% |
| 2014 | -$0.14 B | 21.26% |
| 2013 | -$0.12 B | 277.02% |
| 2012 | -$29.71 M | -17.32% |
| 2011 | -$35.93 M | 71.58% |
| 2010 | -$20.94 M | 35.02% |
| 2009 | -$15.51 M | -11.59% |
| 2008 | -$17.55 M | -47.02% |
| 2007 | -$33.11 M | 0.38% |
| 2006 | -$32.99 M | 88.3% |
| 2005 | -$17.52 M | -30.06% |
| 2004 | -$25.05 M | 32.69% |
| 2003 | -$18.88 M | -25.52% |
| 2002 | -$25.35 M | 64.52% |
| 2001 | -$15.41 M |
Earnings for similar companies or competitors
| Company | Earnings | Earnings differencediff. | Country |
|---|---|---|---|
 Gilead Sciences GILD | $7.23 B | -1,193.57% | 🇺🇸 USA |
 PTC Therapeutics
PTCT | -$0.73 B | 10.12% | 🇺🇸 USA |
 Novavax NVAX | -$0.54 B | -19.01% | 🇺🇸 USA |
 Alnylam Pharmaceuticals
ALNY | -$0.39 B | -42.12% | 🇺🇸 USA |
 Insmed INSM | -$0.65 B | -2.17% | 🇺🇸 USA |
 BioCryst Pharmaceuticals
BCRX | -$0.24 B | -64.56% | 🇺🇸 USA |
 Avidity Biosciences RNA | -$0.21 B | -69.44% | 🇺🇸 USA |